APA
Juillerat P., Wasan S. K., Fowler S. A., Friedman S., Pabby V. K., Coukas J. A., Barto A. E., Pellish R., Germansky K. A., Cheifetz A. S., Korzenik J. R., Farraye F. A. & Yajnik V. (20140519). Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. : Inflammatory bowel diseases.
Chicago
Juillerat Pascal, Wasan Sharmeel K, Fowler Sharyle A, Friedman Sonia, Pabby Vikas K, Coukas Jennifer A, Barto Amy E, Pellish Randall, Germansky Katharine A, Cheifetz Adam S, Korzenik Joshua R, Farraye Francis A and Yajnik Vijay. 20140519. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. : Inflammatory bowel diseases.
Harvard
Juillerat P., Wasan S. K., Fowler S. A., Friedman S., Pabby V. K., Coukas J. A., Barto A. E., Pellish R., Germansky K. A., Cheifetz A. S., Korzenik J. R., Farraye F. A. and Yajnik V. (20140519). Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. : Inflammatory bowel diseases.
MLA
Juillerat Pascal, Wasan Sharmeel K, Fowler Sharyle A, Friedman Sonia, Pabby Vikas K, Coukas Jennifer A, Barto Amy E, Pellish Randall, Germansky Katharine A, Cheifetz Adam S, Korzenik Joshua R, Farraye Francis A and Yajnik Vijay. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. : Inflammatory bowel diseases. 20140519.